Entered on 08-06-2016
On Thursday 2nd of June 2016 the first patient was enrolled in the WP3 MERMAIDS ARBO study by the clinical team in Cluj Napoca, Romania.
More information on the Arbovirus study can be found on the PREPARE Virtual Learning Centre
Entered on 04-05-2016
PREPARE has been preparing its network in order to rapidly identify, diagnose and collect crucial clinical data in case autochthonously-transmitted Zika arrives in Europe.
The protocol of the PREPARE ARBO virus study in the Balkans that will begin in May 2016 has been modified so that adult Zika cases, both those presenting acutely or with GBS i...
Entered on 27-04-2016
The 3rd annual PREPARE meeting was organized in Madrid on 20-21 April 2016.
Presentations from the meeting can be found in the PREPARE member area after logging in.
Entered on 20-04-2016
On Monday 11th of April the Intensive Care Unit of the University Medical Center in Utrecht recruited the first patient in the WP5 AD-SCAP study. More information on this trial can be found on the PREPARE Virtual Learning Center.
Entered on 13-04-2016
PREPARE presented an overview of the project in the ESCMID Networking Corner on the 26th European Congress of Clinical Microbiology and Infectious Diseases, 9-12 April 2016, Amsterdam, the Netherlands.
Download the poster here
Entered on 06-04-2016
A 3-day Arbovirus workshop organised in collaboration with PREPARE WP3, 7 and 9 and ESCMID were held successfully in Thessaloniki, Greece on 7-9 March.
The workshop was attended by 41 participants and faculty from 22 European countries and a wide range of organisations. The workshop which consisted of a mix of presentations and interactive sessions, covered an o...
Entered on 20-01-2016
On Friday 15th of January, the Llanedeyrn Health Centre in Cardiff recruited the first ALIC4E patient!
More information on the ALIC4E trial on our Virtual Learning Platform.
Entered on 08-01-2016
PhD student at the Cardiff University to conduct research on Barriers and solutions to the recruitment of research participants during infectious disease pandemics/epidemics
PREPARE is collaborating with ISARIC in response to the Zika virus outbreak. Read the article.
Entered on 04-12-2015
Janssen Diagnostics, part of the Johnson & Johnson family of companies (NYSE: JNJ) and Biocartis (Euronext Brussels: BCART), an innovative molecular diagnostics company, today announced the launch of their first infectious disease test on the Idylla™ platform. The Idylla™ Respiratory IFV-RSV Panel has been developed by Janssen Diagnostics and is intend...
Menno de Jong